| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 27, 2002
Revised on May 1, 2003
Accepted on May 5, 2003
From the Divisions of Molecular Cardiovascular Biology (P.B.B., H.O., J.D.M., K.E.Y.) and Developmental Biology (R.R.W.), Children's Hospital Medical Center Cincinnati, Cincinnati, Ohio.
* To whom correspondence should be addressed. E-mail: yutzey{at}chmcc.org.
Activation of the nuclear factor of activated T-cell (NFAT) family of transcription factors is associated with changes in gene expression and myocyte function in adult cardiac and skeletal muscle. However, the role of NFATs in normal embryonic heart development is not well characterized. In this report, the function of NFATc3 and NFATc4 in embryonic heart development was examined in mice with targeted disruption of both nfatc3 and nfatc4 genes. The nfatc3-/-nfatc4-/- mice demonstrate embryonic lethality after embryonic day 10.5 and have thin ventricles, pericardial effusion, and a reduction in ventricular myocyte proliferation. Cardiac mitochondria are swollen with abnormal cristae, indicative of metabolic failure, but hallmarks of apoptosis are not evident. Furthermore, enzymatic activity of complex II and IV of the respiratory chain and mitochondrial oxidative activity are reduced in nfatc3-/-nfatc4-/- cardiomyocytes. Cardiac-specific expression of constitutively active NFATc4 in nfatc3-/-nfatc4-/- embryos prolongs embryonic viability to embryonic day 12 and preserves ventricular myocyte proliferation, compact zone density, and trabecular formation. The rescued embryos also maintain cardiac mitochondrial ultrastructure and complex II enzyme activity. Together, these data support the hypothesis that loss of NFAT activity in the heart results in a deficiency in mitochondrial energy metabolism required for cardiac morphogenesis and function.
This article has been cited by other articles:
![]() |
R. Ventura-Clapier, A. Garnier, and V. Veksler Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha} Cardiovasc Res, July 15, 2008; 79(2): 208 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nagendran, V. Gurtu, D. Z. Fu, J. R.B. Dyck, A. Haromy, D. B. Ross, I. M. Rebeyka, and E. D. Michelakis A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 168 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Evans-Anderson, C. M. Alfieri, and K. E. Yutzey Regulation of Cardiomyocyte Proliferation and Myocardial Growth During Development by FOXO Transcription Factors Circ. Res., March 28, 2008; 102(6): 686 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, W. H. Yuen, J. Fu, G. Huang, A. J. Melendez, F. B. M. Ibrahim, H. Lu, and X. Cao The Mitochondrial Respiratory Chain Controls Intracellular Calcium Signaling and NFAT Activity Essential for Heart Formation in Xenopus laevis Mol. Cell. Biol., September 15, 2007; 27(18): 6420 - 6432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonnet, G. Rochefort, G. Sutendra, S. L. Archer, A. Haromy, L. Webster, K. Hashimoto, S. N. Bonnet, and E. D. Michelakis The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted PNAS, July 3, 2007; 104(27): 11418 - 11423. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Alfieri, H. J. Evans-Anderson, and K. E. Yutzey Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1887 - C1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Cho, K. Yao, A. M. Bode, H. R. Bergen III, B. J. Madden, S.-M. Oh, S. Ermakova, B. S. Kang, H. S. Choi, J.-H. Shim, et al. RSK2 Mediates Muscle Cell Differentiation through Regulation of NFAT3 J. Biol. Chem., March 16, 2007; 282(11): 8380 - 8392. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Nilsson, Z.-W. Sun, J. Nilsson, I. Nordstrom, Y.-W. Chen, J. D. Molkentin, D. Wide-Swensson, P. Hellstrand, M.-L. Lydrup, and M. F. Gomez Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1167 - C1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. C. Yang, H. Y. Suk, X. Yang, O. Olabisi, R. Y. L. Yu, J. Durand, L. A. Jelicks, J.-Y. Kim, P. E. Scherer, Y. Wang, et al. Role of Transcription Factor NFAT in Glucose and Insulin Homeostasis Mol. Cell. Biol., October 15, 2006; 26(20): 7372 - 7387. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, X. Xie, X. Zhu, J. Zhu, C. Hao, Q. Lu, L. Ding, Y. Liu, L. Zhou, Y. Liu, et al. Stimulatory Cross-talk between NFAT3 and Estrogen Receptor in Breast Cancer Cells J. Biol. Chem., December 30, 2005; 280(52): 43188 - 43197. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Asher, R. Finberg, F. Wegmann, S. Butz, F. G. Rathjen, K. Wolburg-Buchholz, H. Wolburg, and D. Vestweber CAR might provide a survival signal for myocardial cells J. Cell Sci., December 15, 2005; 118(24): 5679 - 5680. [Full Text] [PDF] |
||||
![]() |
S. Abbasi, B. Su, R. E. Kellems, J. Yang, and Y. Xia The Essential Role of MEKK3 Signaling in Angiotensin II-induced Calcineurin/Nuclear Factor of Activated T-cells Activation J. Biol. Chem., November 4, 2005; 280(44): 36737 - 36746. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lipskaia, F. del Monte, T. Capiod, S. Yacoubi, L. Hadri, M. Hours, R. J. Hajjar, and A.-M. Lompre Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat Circ. Res., September 2, 2005; 97(5): 488 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, C. Zhang, N. Dronadula, Q. Li, and G. N. Rao Blockade of Nuclear Factor of Activated T Cells Activation Signaling Suppresses Balloon Injury-induced Neointima Formation in a Rat Carotid Artery Model J. Biol. Chem., April 15, 2005; 280(15): 14700 - 14708. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Small, A. S. Warkman, D.-Z. Wang, L. B. Sutherland, E. N. Olson, and P. A. Krieg Myocardin is sufficient and necessary for cardiac gene expression in Xenopus Development, March 1, 2005; 132(5): 987 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhou, B. Wu, K. L. Tompkins, K. L. Boyer, J. C. Grindley, and H. S. Baldwin Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart Development, March 1, 2005; 132(5): 1137 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goffart, J.-C. von Kleist-Retzow, and R. J. Wiesner Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy Cardiovasc Res, November 1, 2004; 64(2): 198 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, N. Dronadula, and G. N. Rao A Novel Role for Nuclear Factor of Activated T Cells in Receptor Tyrosine Kinase and G Protein-coupled Receptor Agonist-induced Vascular Smooth Muscle Cell Motility J. Biol. Chem., September 24, 2004; 279(39): 41218 - 41226. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |